Prostate Cancer Clinical Trials

Showing 1581-1600 of 2,150 trials

Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)

NCT01118741

disulfiram is a DNA methyltransferase inhibitor that may provide benefit for patients with prostate cancer by restoring tumor suppressor genes.

Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins19 participantsStarted May 2010

Baltimore, Maryland, United States • Durham, North Carolina, United States • Philadelphia, Pennsylvania, United States

COMPLETEDNA

A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study

NCT02640131

The burden of sexual dysfunction after prostate cancer surgery is responsible for the single greatest impact on patient/partner health-related quality of life; substantially more so than concern for cancer recurrence, or any other post-surgery side-effect. Consequently, there is a great need for progressive and distributable sexual health rehabilitation interventions designed to uphold intimacy and optimal sexual health. If the biomedical-psychosocial intervention is ultimately found beneficial, it will result in: 1) an empirically-based intervention that helps patients/partners maintain optimal health-related quality of life after prostate cancer surgery, and 2) a highly structured protocol and manualized intervention that is translatable to other treatment groups (e.g. radiation therapy) and University/Community-based hospitals.

Prostate CancerErectile DysfunctionSexual Dysfunction

University Health Network, Toronto65 participantsStarted Jan 2014

Toronto, Ontario, Canada

Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)

A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study

Related Searches

Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)

Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer

Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment

Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer

A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)

Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer

Evaluation of the Metastasis and Recurrence of Prostate Cancer

Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment

Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer

Focal Therapy for Prostate Cancer Using HIFU

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

MRI and Biomarkers in Prostate Cancer

Prostate Magnetic Resonance Imaging in Patient With Previous Negative Biopsies

The Efficacy and Safety of Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Focal Therapy

Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections

Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer

The Accuracy of Modified TTMB in the Spatial Distribution of Prostate Cancer